CentralCharts: Supercharge your portfolio with groundbreaking tools.

Total Revenue Increased 54% Sequentially; GAAP Gross Margin Expanded to 46.4%, Non-GAAP to 66.4% SAN JOSE, CA / ACCESSWIRE / May 13, 2024 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a global leader in mmWave technology for 60 GHz unlicensed and 5G licensed networks, today announced financial results for the first quarter ended March 31, 2024. Management Commentary "First quarter revenue increased sequentially and was above the midpoint of guidance, driven by increased product...

Increased Adoption of Dental Lasers and Improved Cost Structure Position Company for Sustained Long Term Growth and Success LAKE FOREST, CA / ACCESSWIRE / May 13, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported its financial results for the first quarter ended March 31, 2024. First Quarter Financial Highlights Generated increased adoption of its industry-leading laser, with approximately 67% of U.S. Waterlase sales coming from new customers and...

ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. ANNOUNCES PLAN FOR FULL REDEMPTION OF 2019 VARIABLE RATE MUNIFUND TERM PREFERRED SHARES AND ISSUANCE OF NEW VARIABLE RATE DEMAND PREFERRED SHARES AS SUBSTITUTE LEVERAGE PR Newswire NEW YORK, May 13, 2024 NEW YORK , May 13, 2024 /PRNewswire/ -- AllianceBernstein National Municipal Income Fund, Inc. (the "Fund"; NYSE: AFB), a registered closed-end investment company, announced today that it intends to commence a private offering of up to $100...

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING, Pa., May 13, 2024 BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgical treatment for recurrent respiratory papillomatosis (RRP) Planning initiation of confirmatory trial for INO-3107 based on FDA feedback Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZI TM (toripalimab-tpzi)...

Astrana Health, Inc. to Participate in Upcoming Investor Conference PR Newswire ALHAMBRA, Calif., May 13, 2024 ALHAMBRA, Calif. , May 13, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the BofA...

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire CUPERTINO, Calif., May 13, 2024 - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, May 13th at 4:30 p.m. ET CUPERTINO, Calif. , May 13, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March 31, 2024 and provided a business update. "We are pleased...

The Andersons to Present at BMO Global Farm to Market Conference PR Newswire MAUMEE, Ohio, May 13, 2024 MAUMEE, Ohio , May 13, 2024 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces that it will present at the BMO Capital Markets Global Farm to Market Conference on Wednesday, May 15, 2024 . Chief Operating Officer Bill Krueger and Executive Vice President and Chief Financial Officer Brian Valentine will speak at the conference at 8:45 a.m. Eastern Time . The Andersons presentation...

QuickLogic Reports First Quarter Fiscal 2024 Results, On Track for Revenue Growth of 30% and Positive Cash Flow in 2024 PR Newswire SAN JOSE, Calif., May 13, 2024 SAN JOSE, Calif. , May 13, 2024 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK) ("QuickLogic" or the "Company"), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI solutions, today announced its financial results for the fiscal first quarter that ended March 31, 2024 . Recent Highlights Achieved greater...